Stoke Therapeutics, Inc. (STOK) Misses Q2 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: STOK) | Delayed: 26.46 +0.05 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.41 | 52 Week High | $ | |||
| Open | $26.39 | 52 Week Low | $ | |||
| Day High | $27.00 | P/E | N/A | |||
| Day Low | $26.22 | EPS | $ | |||
| Volume | 128,162 | |||||
